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Acylation of desoctapeptide-(1323-3°) -insulin pentamethyl ester 
(II), insulin arid insulin ' hexamethyl ester was carried out with 
Boc-azide in dimethylformamide in the presence of 1,1,3,3-tetra-
methylguanidine as a base and 1,2,4-triazole as an activator to give 
very homogeneous di-Boc-desoctapeptide-(B23- 30)-insulin p~ntame­
thyl ester (III), tri-Boc-insulin (IV) and tri-Boc-insulin hexamethyl 
ester (V) , respectively, in high yield (> 900/o). The degree of sub-
stitution of the products was assayed by a simple and sensitive test, 
based on the fluorescence reaction with primary amines, and expres-
sed as the fluorescence intensity relative to that produced by an 
equimolar amount of free insulin. A comparison of the fluorescence 
intensities of III and IV prepared under various conditions indicates 
that (a) the Boc-azide - 1,1,3,3-tetramethylguanidine - 1,2,4-triazole 
combination is more effectiv.e than the Boc-azide - imidazole and 
Boc-azide - triethylamine acylating systems, and (b) the presence 
of 1,2,4-triazole is·essential for the acylating efficiency of the system 
employed. 
INTRODUCTION 
Complete and selective protection of the amino groups in insulin and its 
derivatives with the tert-butyloxycarbonyl (Boe) groups has been often used in 
procedures involving specific reactions on the other parts of the peptide mole-
cule. Levy and Carpenter1•2 synthesized the fully protected tri-Boc-insulin (IV) 
by reacting insulin hydrochloride with Boc-azide in dimethylformamide in the 
presence of triethylamine, and the same procedure ·has been used3•4 to acylate 
desoctapeptide-(B~3-30)-insulin pentamethyl ester (11) into the di-Boe-derivative 
III. As the amino group of phenylalanine-B1 has a greatly reduced reactivity 
tow ard Boc-azide relative to the amino group of glycine-A' and the £-amino 
group of lysine-Bz9 , conditions were elaborated5•6 under which the Boe group 
can be applied to residues A 1 and B 29 with only a minor reaction on residue B 1. 
Levyi has shown that the extent of acylation of insulin with Boc-aziqe in 
dimethylformamide depends on the excess of reagent used, on the reaction ·time 
and on the nature of the base employed ; thus, the use of imidazole instead of 
triethylamine markedly decreased the rate of acylation. 
We report here on a modified Boe-protection procedure, involving 1,1,3,3-
-tetramethylguanidine as a base and 1,2,4-triazole as an activator, by which 
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very homogenous di-Boc-desoctapeptide-insulin pentamethyl ester (III), tri-Boc-
-insulin (IV) and tri-Boc-insulin hexamethyl ester (V) , respectively, was synthes-
ized in high yield. In order to determine the degree of substitution of the 
products obtained, a simple and sensitive test, based on the fluorescamine 
reaction8 with primary amines, has been elaborated. 
RESULTS AND DISCUSSION 
Esterification of porcine insulin into the hexamethyl ester I was performed 
by the boron trifluoride-methanol procedure as described by Gattner et al.9, 
except that we omitted the purification step on CM Sephadex column with 
sodium acetate - urea buffer, because of partial decomposition of the product 
during fractionation. In passing, it may be noted that our attempts to prepare 
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I by treating3 insulin with diazomethane were also unsuccessfull; the reaction 
performed under various (but strictly controlled) conditions led, as already 
reported\ either to formation of methylated by-products, or to incomplete 
esterification, or to both. 
The tryptic incubation4 of I was performed at pH 7.5 and 25 °c for 24 h , 
followed by precipitation of the digest at pH 8.4 and fractionation of the 
precipitate on a Sephadex G-50 (fine) column with 1 mol dm-3 acetic acid 
(Figure 1.). Desoctapeptide-(B23- 30)-insulin pentamethyl ester (II) emerging in 
the peak C was completely free of the starting I, as shown by cellogel electro-
phoresis at pH 4.8 and by the amino acid composition of the hydrolyzate 
(Table I). The residue obtained in section B was subjected to a second fract-
ionation to afford an additional amount (C1 ) of II not contaminated with I; total 
yield: 47.6°/o. 
Several improvements of the commonly used procedures for the introduction 
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Figure 1. Gel filtration of Sephadex G-50 (fine) of the tryptic digest of I. - The precipitate 
derived from digestion of I (300 mg) was dissolved in 1 mol dm-• AcOH (1.5 ml) and applied to 
a column (2.5 X 100 cm) of Sephadex G-50 (fine) which was equilibrated and developed with 
1 mol dm-• AcOH. Elution was performed at 15 ml/60 min, and fractions (3 ml) were pooled 
as indicated and lyophilized. C = desoctapeptide-(B•M•)-insulin pentamethyl ester (II), 90.7 mg. 
The residue left in B was re-run on the same column to give an additional amount (35 .2 mg) · 
of material eluting at the position of peak C (C1) . 
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TABLE :I 
Amino Acid Composition of Desoctapeptide-insulin Pentamethyl Ester (II) and 
· di~Boc-Desoctapeptide-insulin Pentamethyl Ester (III) 0 
Found: 
Amino Acid Cale. for II II, from 111, from Residueb and III 
Peak C Peak C1 Expt. no. 5 
Asp (3) 3 3.00 3.00 3.00 
Thr (2) 1 1.12 1.00 0.89 
Ser (3) 3 2.91 2.84 2.87 
·Glu (7) 7 7.11 7.20 6.99 
Pro (1) 0 0.00 0.00 0.00 
Gly (4) 3 3.04 2.87 3.01 
Ala (2) 1 1.13 1.06 1.10 
Cys "(6) 6 4.50 3.87 4.56 
Val (4) 4 2.41 2.45 2.86 
Ile (2) 2 0.89 1.03 0.93 
Leu (6) 6 6.10 5.97 6.90 
Tyr (4) 3 2.63 2.70 2.76 
Phe (3) 1 0.95 0.65 0.84 
His (2) 2 2.01 1.89 1.91 
Lys (1) 0 0.00 0.00 0.00 
Arg (1) 1 0.94 0.90 0.98 
' Values found are given as molar ratios with respect to aspartic acid ~ 3 and they are not 
corrected for destruction. 
" Values in brackets refer to the number of amino acid residues in native porcine insulin. 
Bram10 observed that acylation of amino acid benzyltrimethylammonium 
(»Triton B«) salts in dimethylformamide or dimethylsulphoxide with tert-
-butylphenyl carbonate proceeds in significantly higher yields when 1,2,4-
-triazole is added to the reaction mixture. He suggested two explanations for 
the promoted reaction: either the highly reactive N 1-Boc-l,2,4-triazole is formed 
in situ or the unchanged triazole acts as a bifunctional catalyst. Acylation of 
amino acid 1,1,3,3-tetramethylguanidinium salts with Boc-azide in dimethyl-
formamide has been reported11 to give excellent yields of Boe-amino acids. 
In general, the value of tetramethylguanidine as a base that has no effect on 
racemization over a broad pH range and does not act as an acyl acceptor has 
been outlined in several areas of peptide chemistry (e. g., ref 12-14). 
We have examined whether modifications of the above type are also ef-
fective when applied to the insulin series. Thus, a number of experiments was 
carried out in which the pentamethyl ester II and insulin, respectively, was 
treated with varying excesses of Boc-azide in dimethylformamide at controlled 
pH in the presence of 1,1,3,3-tetramethylguanidine, with or without addition of 
1,2,4-triazole. In parallel runs, the synthesis of di-Boc-desoctapeptide-insulin 
pentamethyl ester (III) a:nd tri-Boc-insulin was carried out under conditions 
of the existing methods2•4•7. We found benzyltrimethylammonium hydroxide 
unsuitable as a base, mainly because of its tendency to contaminate the product. 
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The degree of substitution of the products was assayed by fluorometric 
technique using fluorescamine to detect the primary amino groups that have 
not undergone acylation. The assays were run in dimethylformamide, and, 
under the conditions employed, Zn-free insulin gave a clear linear response in 
amounts ranging from 0.5 to 15 nmoles. The fluorescence intensity of a particular 
sample was expressed relative to the fluorescence intensity of an equimolar 
amount of Zn-free insulin. The use of insulin as the standard is only arbitrary 
because it does not take into account possible modifications of the fluorescence 
yield arising from different degrees of reactivity of buried and exposed amino 
groups and different sensitivity of individual emitting groups. On the other 
hand, the values obtained with samples of a given compound are directly 
comparable. The assay, in addition to being simple and reproducible, prov2d 
to be much more sensitive than the previously used ninhydrin method. 
The reaction conditions of Boe-protection reaction and the relative fluo-
rescence intensities of the products obtained in typical experiments are sum-
marized in Table II. By comparing experiment no. 1 with no. 2, and no. 3 with 
no. 4, it follows that the acylating efficiency of the system Boc-azide - 1,1,3,3-
-tetramethylguanidine - 1,2,4-triazole 'is higher than that of Boc-azide 
TABLE II 
Reiativ e FLuorescence Intensities of di-Boc-Desoctapeptide-insuHn PentamethyL 
Ester (III) , tri-Boc-InsuHn (IV) and tri -Boc-InsuHn HexamethyL Ester (V) Prepared 
Under Various Conditions• 
-----· 
Conditions of Synthesis Fluorescence at conc,/O/o: 
E x pt. Compound M0la r excess of no. Method" Boc-azide over 10 nmol/ml 1 nmol/ml 
amino groups 
Insulin 100 100 
(II)° 61.3 60.3 
1. (III) A (4) 315 1.3 n . d . 
2. {III) c (4) 315 8.5 n . d . 
3. (III) A (4) 180 1.2 n . d . 
4. (III) B- 180 4.9 4.7 
5. (III) A (2) 180 1.1 1.2 
6. (III) D- 180 11.l 11.5 
7. (III) D- 315 11.6 11.5 
8. (IV) A (4) 250 1.2 n . d. 
9. (IV) A (2) 120 1.2 1.3 
10. (IV) B- 120 3.5 3.1 
11. (V) A (4) 250 1.1 n . d. 
a Measured in dimethylformarnide at excitation 395 nm and emission 490 nm. The fluorescence 
intensity is expressed relative t o that of Zn-free insulin at the same molar concentration. 
" Boc-lation performed in the presence of: A = 1,1,3,3-tetramethylguanidine + 1,2,4-triazole (mg 
triazole/µmole substrate), 38 •c, 6 h; B = trlethylamine, 40 •c, 5 h, ref 2 and 4; C = irnidazole 
(mglµmole substrate) , 38 •c, 6 h , ref 7; D = 1,1,3,3-tetramethylguanidine, 38 •c, 6 h. All of the 
products were precipitated with ether, centrifuged off, washed with ether (3 x) and dried. 
c Desoctapeptide-insulin pentamethyl ester 
n. d. = not determined 
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imidazole and Boc-azide - triethylamine, respectively. As shown in experiments 
no. 5 and 9, the same acylating efficiency could also be achieved with a reduced 
amount of triazole; in addition, a variation of experiment no. 9 by shortening 
the reaction time from 6 to 5 h was without consequences on the relative 
fluorescence intensity of the product. Experiments no. 6 and 7 revealed that 
the presence of 1,2,4-triazole is essential for the promotion of the reaction: 
Boc-lation of II performed in the presence of tetramethylguanidine, but without 
addition of triazole, led to incomplete substitution, even when larger excesses 
of Boc-azide were used. 
The fully Boe-substituted products prepared by the triazole-promoted 
reaction were obtained in yields over 900/o. For characterization, they were 
subjected to amino acid analysis and deprotection with trifluoroacetic acid; the 
amino acid composition of III, prepared in experiment no. 5 is given in Table I. 
All of the Boe-protected derivatives gave, upon treatment with trifluoroacetic 
acid, a product which possessed on cellogel electrophoresis (pH 4.8 and 6.5) the 
same mobilities as desoctapeptide-insulin pentamethyl ester (II), insulin and 
insulin hexamethyl ester (I), respectively. The product regenerated from IV 
gave the correct amino acid composition of insulin; it was converted into the 
Zn-salt which on polyacrylamide electrophoresis (pH 9.5) behaved identically 
as the starting Zn-insulin and, as determined by the mouse fall test, had a 
biological activity that was indistinguishable from native insulin. 
The data presented suggest that the acylating effiGiency of the Boc-azide 
- 1,1,3,3-tetramethylguanidine - 1,2,4-triazole system might also be usefully 
applied to semisynthetic work with other peptides and proteins. 
EXPERIMENTAL 
Materials 
Porcine insulin, crystalline zinc-salt, was obtained from PLIVA (lot no. 4,047,022, 
24.4 I.U./mg) and was used throughout. Zn-free insulin was prepared4•15 by adding 
Na2EDTA (18.8 mg) to zinc-insulin (500 mg) in 20/o acetic acid (25 ml) and adjusting 
the solution to pH 5.4 with 0.2 mol dm-3 NaOH; the resulting precipitate was centri-
fuged off, washed with water, ethanol and ether and dried. Insulin hexamethyl ester (I) 
was prepared from Zn-free insulin by the BF3-MeOH esterification as described by 
Gattner et al.9 ; the product obtained by precipitation with ether was centrifuged off, 
washed (3 x) with ether, dried overnight in a desiccator and then used directly in 
the tryptic digestion step. 
Fluorescamin (Fluram) was from Hoffmann La Roche and 1,2,4-triazole (puriss.) 
from Fluka. tert-Butyloxycarbonyl (Boe) azide (prepared from Boc-hydrazide, Fluka) 
was redistilled before use; fraction with b. p . 64-68 °C/85 Torr* was used. N,N-Di-
methylformamide (DMF) was distilled over CaH2 and kept in a stoppered containe! 
over molecular sieve (A-4, Fluka). 1,1,3,3-Tetramethylguanidine (Eastman) was re-
distilled, and fraction with b. p . 91-93 °C/115 Torr* was used. Trypsin, bovine was 
from Sigma (Type XI, chymotrypsin free). 
Methods 
All separations on columns were carried out at 4 °c. Products were recovered by 
evaporation of the eluates to small volume (rotary evaporator, bath temp. < 35 °C) 
followed by lyophilization. 
Electrophoresis on cellulose acetate was performed on strips (2.5 x 14 cm) in a 
standard electrophoresis apparatus (Chemetron) at 200 V and at pH 4.8 (0.1 mol dm-3 
pyridine/6 mol dm-s urea buffer adjusted with acetic acid) or at pH 6.5 (0.065 mol dm-3 
phosphate/7 mol dm-3 urea buffer). The strips were stained with 0.250/o solution of 
* 1 torr = 133.322 Pa 
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Ponceau S in 3°/o trichloroacetic acid. Disc-gel electrophoresis was carried out on 
acrylamide gel, prepared by the standard technique, at pH 9.5 (0.05 mol dm--a Tris/0.03 
mol dm-a glycine); cross-linkage of the spacer gel was 2.50/o and of running gel 150/o. 
The bands were stained with Coomassie Brilliant Blue R-250 (Sigma). 
Amino acid analyses were made on a LKB automatic amino acid analyzer, 
model BC 200. All hydrolyses were performed in 6 mol dm-3 HCl in sealed evacuated 
tubes at 120 °c for 14 h. Samples were added in 0.2 mol am-a sodium citrate buffer 
(pH 2.2), and analyses were run at 55 °c with three sodium citrate buffers : (1) 0.2 
mol dm-3, pH 3.25, (2) 0.2 mol am-a, pH 4.25, and (3) 1.2 mol ctm·3, pH 6.45. 
The fluorescence intensity produced by the reaction of fluorescamine with 
primary amino groups was measured on an Farand MK fluorescence spectrophoto-
meter with the excitation wavelength at 395 nm and emission at 490 nm without 
filter, using 1 X 1 X 3 cm quartz cell. Standard Zn-free insulin and samples (1 µmole 
each) were prepared as DMF (10 ml) solutions, and aliquots of 0.3 and 0.03 ml, 
respectively, were taken and made up to 2.5 ml with DMF. Then 0.5 ml of a freshly 
prepared solution of fluorescamine in acetone (3 mg/10 ml) was added, and the tube 
was immediately agitated with a vortex mixer. Fluorescence was measured at 25 °C 
within 10 min and 3 h after addition of the reagent and expressed as relative to that 
of an equal molar concentration 6f the standard which had been taken arbitrarily 
as 1000/o. A linear response with Zn-free insulin was obtained from 0.5 to 15 nmoles, 
and no change in fluorescamine-reactive material was seen with time ; the contribut-
ion of the blank (DMF + fluorescamine) W f! S negligible. 
Desoctapeptide-(B23- 30)-insulin Pentamethyl Ester (II) 
The incubation was performed in a thermostated vessel in the pH-Stat (Radio-
meter Copenhagen, units : pH Meter 26, titrator TTTll and autoburette ABU 12) under 
nitrogen atmosphere. The hexamethyl ester I (300 mg, 0.02 mmol)' was suspended 
in water (75 ml) , adjusted with 0.1 mol dm-3 NaOH to pH 7.5 and, after preincubation 
at 25 -0c for 30 min, trypsin (15 mg) dissolved in 4 X 10-a mol ctm·a hydrochloric acid 
containing 1 x 10-2 mol am-3 CaC12 (2.4 ml) was added to the solution. The digestion 
was allowed to proceed at pH 7.5 (automatic correction of pH with 0.1 mol am-a NaOHJ 
and 25 °c for 24 h , whereupon the reaction was stopped by adjusting to pH 8.4 with 
0.1 mol ctm·a NaOH. The resulting precipitate was collected by centrifugation and 
subjected to fractionation on Sephadex G-50 (fine) as described in Figure 1. After 
lyophilization of peak tubes, a total of 125.9 mg of fluffy material was obtained which 
was characterized (Table I) as II free of the starting hexamethyl ester I. 
NA1, BB1-di-tert-Butyloxycarbonyl-desoctapeptide-(B23- 30)-insulin Pentamethyl 
Ester (III) 
(a) In the presence of 1,1,3,3-tetramethylguanidine and 1,2,4-triazole. - To a 
solution of the above II (60 mg, 12 µmole, 24 itequiv. of NH2 groups) in DMF (6 ml) 
was added at room temperature 1,2,4-triazole (20 mg, 0.24 mmol) in DMF (1 ml) 
followed by alternative addition of Boc-azide (614 mg, 178 X excess) and 1,1,3,3-
-tetramethylguanidine (- 0.2 mol dm-a in DMF) at such a r ate (10 min) that the 
apparent pH of the reaction mixture was kept (pH meter) within 9.0-9.5. The reaction 
was allowed to proceed at 38 °c for 6 h , and the pH of the solution was r eadjusted to 
9.4-9.5 with 0.2 mol am-a tetramethylguanidine solution after the first, third and 
fifth hour of incubation. After cooling, anhydrous ether was added to the solution, 
and, after keeping overnight in refrigirator, the resulting precipitate was centrifuged 
off, washed with ether (3 X) and dried. The white powder (56.4 mg, 93.90/o) was 
characterized by amino acid composition (Table I), relative fluorescence intensity 
(Table II, expt. no. 5) and deblocking with trifluoroacetic acid as III.-
The same treatment of II (60 mg) but with a higher amount of 1,2,4-triazole 
(40 mg) and the same or higher amount of Boc-azide (614 and 1.075 mg, resp.) afforded 
III (yields 92.5-95.30/o); the relative fluorescence intensity of these products is given 
in Table II (expts. no. 1 and 3). 
A sample of III was dissolved in DMF-hexamethylphosphoramide (1 : 1, 25 ml) 
and precipitated by subsequent addition of water (6 ml); after standing overnight in 
refrigirator, the white crystalline precipitate was centrifuged off, washed with ether 
(3 X) and dried ; yield: 27 mg. The relative fluorescence intensity of this specimen 
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was virtually identical (l.20/o) to that of III which was not submitted to additional 
purification. 
(b) In the presence of imidazole. - .II (60 mg) was treated with Boc-azide 
(1 075 mg) and imidazole (40 mg) in DMF (8 ml) exactly as described7 for the pre-
paration of tri-Boc-insulin to give 55 mg of III which fluorescence intensity relative 
to insulin is shown in Table II (expt. no. 2). 
(c) In the presence of triethylamine. - The reaction was performed as described 
by Weitzel et al4• to give III (Table II, expt. no. 4) in 91.50/o yield. 
NA\ NBt, NB29 -tri-tert-Butyloxycarbonyl- insulin (IV) 
Samples of insulin hydrochloride16 (60 mg, 10.2 µmole, 30.6 µequiv. of NH2 groups) 
in DMF (6 ml) were treated with Boc-azide (520 mg, 3.63 mmole or 1 075 mg, 7 mmol) 
in the presence of 1,2,4-triazole (40 or 20 mg) and 1,1,3,3-tetramethylguanidine as 
described for the preparation of III under (a). The ether-precipitated apd -washed 
products were characterized by fluorescence assay (Table II, expts. no. 8 and 9), amino 
acid composition and deblocking with trifluoroacetic acid; yields: 93.5-95.5°/o. 
N'\1, NB1, NB29 -tri-tert-Butyloxycarbonyl-insulin Hexamethyl Ester (V) 
Insulin hexamethyl ester (I, 32 mg, 5.5 µmol) in DMF (3 ml) was treated with 
Boc-azide (580 mg), 1,2,4-triazole (20 mg) and 1,1,3,3-tetramethylguanidine as described 
for III under (a) to give 31.5 mg, 93.2°/o of V which was characterized by amino acid 
composition, relative fluorescence intensity (Table II, expt. no. 11) and deprotection 
with trifluoroacetic acid. 
Removal of Boe-Protecting Groups 
Deprotection of III, IV and V was performed as described by Levy and Car-
penter2, and the ether-precipitated products were subjected to amino acid analysis 
and cellogel- and disc-electrophoresis. The precipitated protein obtained by treating IV 
(20 mg) with trifluoroacetic acid was dissolved in 0.5 mol dm-3 acetic acid to which 
Zn-acetate in 0.5 mol dm-3 acetic acid (1 mg/ml, 0.33 ml) was added, and the solution 
was adjusted with 5 mol dm·3 ammonium hydroxide to pH 5.81. After standing over-
night in the refrigirator, the precipitate was centrifuged off, washed with ether and 
dried. On cellogel- and disc-electrophoresis (pH 4.8 and 6.5, and pH 9.5, resp.) the 
product behaved identically as the starting Zn insulin, and in the mouse fall test it 
revealed a biological activity equivalent to that of the starting insulin. 
Acknowledgement. We are indebted to Dr. M. Slijepcevic and M. Hadzija, B. Sc., 
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SAZETAK 
Sinteza potpuno Boc-zasticenih insulinskih derivata s Boc-azid - 1,1,3,3-tetrametil-
guanidin - 1,2,4-triazolom kao efikasnim acilirajucim sistemom. - Odredivanje 
stupnja N-supstitucije produkata s pomocu jednostavne i osjetljive reakcije 
s fluorescaminom 
D. Keglevic, S. Vuksan, B . Mulac, B. Lade!iic, S. Iskric i S. Kveder 
Zastita primarnih amino-skupina s tert-butoksikarbonil (Boe) skupinama u de-
soktapeptid- (B23-30)- insulin pentametil esteru, insulinu i insulin-heksametil-esteru pro-
vodena je s Boc-azidom u prisutnosti 1,1 ,3,3-tetrametilguanidina kao baze i 1,2,4-
-triazola kao aktivatora. Stupanj N- supstitucije u izoliranom d i-Boc-desoktapeptid-
-(B23-30) -insulin-pentametil-esteru, . tri-Boc-insulinu, odnosno tri- Boc-insulin-heksa-
metil- esteru ispitivan je metodom fluorescencije i izrazen kao r elativni intenzitet 
fluorescencije prema intenzitetu sto ga daje ekvimolarna kolicina slobodnog insulina. 
Na ta j nacin ustanovljeno je da je: (a) sistem Boc-azid - 1,1,3,3-tetrametilguanidin -
- 1,2,4- triazol efikasniji nego do sada opisani sistemi za dobivanje Boc-derivata insu-
lina i njegovih deriv9ta, te da je (b) prisutnost 1,2,4-triazola od prirnarne vaznosti za 
efikasnost acilacij e. 
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